immunotherapeutic advancements for glioblastoma
Clicks: 228
ID: 152401
2015
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Popular Article
30.0
/100
227 views
23 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Immunotherapy seeks to improve the body’s immune response to a tumor. Currently, the principal mechanisms employed are: 1) to improve an aspect of the immune response (e.g. T cell activation) and 2) to encourage the targeting of particular antigens. The latter is typically achieved by exposing the immune system to the antigen in question, in vivo, or in vitro followed by re-introduction of the primed cells to the body. The clinical relevance of these approaches has already been demonstrated for solid tumors such as melanoma and prostate cancer. The central nervous system was previously thought to be immune privileged. However we know now that the immune system is highly active in the brain and interacts with brain tumors. Thus, harnessing and exploiting this interaction represents an important approach for treating malignant brain tumors. We present a summary of progress in this area, focusing particularly on immune checkpoint inhibition, vaccines and T cell engineering.
| Reference Key |
eampie2015frontiersimmunotherapeutic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Leonel eAmpie;Eric C Woolf;Christopher eDardis |
| Journal | international journal of heat and technology |
| Year | 2015 |
| DOI |
10.3389/fonc.2015.00012
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.